SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001213900-22-072169
Filing Date
2022-11-14
Accepted
2022-11-14 16:02:04
Documents
1
Group Members
BOHLINI INVEST GMBH

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13D ea168488-13da2vonbohlen_cure.htm SC 13D/A 47916
  Complete submission text file 0001213900-22-072169.txt   49300
Mailing Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076
Business Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076 49 7071 9883 0
CureVac N.V. (Subject) CIK: 0001809122 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91630 | Film No.: 221384897
SIC: 2834 Pharmaceutical Preparations

Mailing Address NEUENHELMER LANDSTRASSE 4 HELDELBERG 2M 69120
Business Address
von Bohlen und Halback Friedrich (Filed by) CIK: 0001918389 (see all company filings)

Type: SC 13D/A